WO2008113916A9 - Pharmaceutical composition containing antibodies directed against the herv-w envelope - Google Patents

Pharmaceutical composition containing antibodies directed against the herv-w envelope Download PDF

Info

Publication number
WO2008113916A9
WO2008113916A9 PCT/FR2008/000166 FR2008000166W WO2008113916A9 WO 2008113916 A9 WO2008113916 A9 WO 2008113916A9 FR 2008000166 W FR2008000166 W FR 2008000166W WO 2008113916 A9 WO2008113916 A9 WO 2008113916A9
Authority
WO
WIPO (PCT)
Prior art keywords
directed against
herv
pharmaceutical composition
envelope
composition containing
Prior art date
Application number
PCT/FR2008/000166
Other languages
French (fr)
Other versions
WO2008113916A3 (en
WO2008113916A2 (en
Inventor
Herve Perron
Original Assignee
Geneuro Sa
Herve Perron
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geneuro Sa, Herve Perron filed Critical Geneuro Sa
Priority to EP08761866A priority Critical patent/EP2117594A2/en
Priority to US12/449,327 priority patent/US20100074894A1/en
Publication of WO2008113916A2 publication Critical patent/WO2008113916A2/en
Publication of WO2008113916A3 publication Critical patent/WO2008113916A3/en
Publication of WO2008113916A9 publication Critical patent/WO2008113916A9/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Abstract

The invention relates to a pharmaceutical composition that contains, as an active ingredient, at least one antibody directed against the HERV-W envelope protein, except for any antibody specifically directed against the binding site between said env protein and the hASCTl or hASCT2 receptor.
PCT/FR2008/000166 2007-02-09 2008-02-11 Pharmaceutical composition containing antibodies directed against the herv-w envelope WO2008113916A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP08761866A EP2117594A2 (en) 2007-02-09 2008-02-11 Pharmaceutical composition containing antibodies directed against the herv-w envelope
US12/449,327 US20100074894A1 (en) 2007-02-09 2008-02-11 Pharmaceutical composition containing antibodies directed against the herv-w envelope

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0700952 2007-02-09
FR0700952A FR2912314B1 (en) 2007-02-09 2007-02-09 PHARMACEUTICAL COMPOSITION COMPRISING ANTIBODIES AGAINST THE HERV-W ENVELOPE

Publications (3)

Publication Number Publication Date
WO2008113916A2 WO2008113916A2 (en) 2008-09-25
WO2008113916A3 WO2008113916A3 (en) 2008-11-27
WO2008113916A9 true WO2008113916A9 (en) 2009-01-22

Family

ID=38457775

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2008/000166 WO2008113916A2 (en) 2007-02-09 2008-02-11 Pharmaceutical composition containing antibodies directed against the herv-w envelope

Country Status (4)

Country Link
US (1) US20100074894A1 (en)
EP (1) EP2117594A2 (en)
FR (1) FR2912314B1 (en)
WO (1) WO2008113916A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2633965T3 (en) 2008-07-08 2017-09-26 Geneuro Sa Therapeutic use of specific ligand in diseases associated with MSRV
US10370417B2 (en) 2011-03-01 2019-08-06 Rutgers, The State University Of New Jersey Methods for the diagnosis of cancer through detection of human endogenous retrovirus WL (HERV-WL) envelope expression
WO2012118974A2 (en) * 2011-03-01 2012-09-07 University Of Medicine And Dentistry Of New Jersey Detection of human endogenous retrovirus expression in cancer and normal cells
EP2949342A1 (en) * 2014-05-28 2015-12-02 Geneuro SA Antiretroviral drug targeting human endogenous retrovirus
JP2018531599A (en) * 2015-10-05 2018-11-01 メタフォラ，バイオシステムズ Receptor binding domain ligands for detection, diagnosis and treatment of pancreatic cancer
MX2018005541A (en) 2015-11-10 2018-08-01 Medimmune Llc Binding molecules specific for asct2 and uses thereof.
EP3351265A1 (en) * 2017-01-20 2018-07-25 Geneuro SA Anti-herv-k envelope antibody and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001031021A1 (en) * 1999-10-28 2001-05-03 Universite De Geneve Multiple sclerosis-related superantigen
FR2865403B1 (en) * 2004-01-23 2009-06-12 Biomerieux Sa COMPOSITION FOR THE TREATMENT OF A PATHOLOGY ASSOCIATED WITH MSRV / HERV-W

Also Published As

Publication number Publication date
WO2008113916A3 (en) 2008-11-27
FR2912314B1 (en) 2012-08-03
EP2117594A2 (en) 2009-11-18
WO2008113916A2 (en) 2008-09-25
US20100074894A1 (en) 2010-03-25
FR2912314A1 (en) 2008-08-15

Similar Documents

Publication Publication Date Title
WO2007106744A3 (en) Anti-5t4 antibodies and uses thereof
WO2009070243A3 (en) Wise binding antibodies and epitopes
WO2009034119A8 (en) Improved derivatives of amylin
WO2008100624A3 (en) Antibodies against erbb3 and uses thereof
WO2008079995A3 (en) Conjugate of natriuretic peptide and antibody constant region
WO2008060705A8 (en) Anti-dll4 antibodies and methods using same
WO2008082669A3 (en) Von willebrand factor- and factor viii-polymer conjugates having a releasable linkage
WO2007076260A3 (en) Farnesoid x receptor agonists
WO2008113916A3 (en) Pharmaceutical composition containing antibodies directed against the herv-w envelope
WO2007130697A8 (en) Anti-ephb4 antibodies and methods using same
IL199216A (en) Monoclonal antibodies against angptl3, pharmaceutical compositions comprising the same and uses thereof
WO2009052400A8 (en) Antibodies that bind to mammalian ngal and uses thereof
WO2007120334A3 (en) Methods and compositions for targeting polyubiquitin
WO2007133290A3 (en) Anti-ox40l antibodies and methods using same
WO2010145792A8 (en) Bispecific antigen binding proteins
WO2008121767A3 (en) Stitched polypeptides
WO2006138343A3 (en) Compositions comprising receptor - associated protein (rap) variants specific for lrp2 and uses thereof
WO2008157356A3 (en) Antibody formulations
WO2006083936A3 (en) Anti-ephb2 antibodies and methods using same
WO2007075525A3 (en) Combination of an iap-inhibitor and a taxane7
WO2009128963A3 (en) Cross-neutralizing human monoclonal antibodies to sars-cov and methods of use thereof
IL211010A (en) Antibody, a hybridoma for producing the antibody, a conjugate comprising the antibody, a pharmaceutical composition comprising the antibody and/or the conjugate and uses thereof
WO2007127506A8 (en) Anti-ephrinb2 antibodies and methods using same
IL200388A (en) Antibody, a hybridoma for producing the antibody, a conjugate comprising the antibody, a pharmaceutical composition comprising the antibody and/or the conjugate and uses thereof
WO2008049990A3 (en) Use of an anti-cd151 antibody in the treatment of cancer

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08761866

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008761866

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12449327

Country of ref document: US